SIRP alpha V2/CD172a hFc Chimera, Human
| ¥3000 | |
| Z05832-100 | |
| 
                                             | 
            |
| 
                        
                             | 
                |
| 
                         | 
                |
| ¥3000 | |
| Z05832-100 | |
| 
                                             | 
            |
| 
                        
                             | 
                |
| 
                         | 
                |
| Species | Human | ||||
| Protein Construction | 
                                                                                                                                                                                
  | 
                                                ||||
| Purity | > 95% as determined by BisTris PAGE | ||||
| Endotoxin Level | Less than 1EU per μg by the LAL method. | ||||
| Biological Activity | Measured by its binding ability in a functional ELISA. Test result was comparable to standard batch. | ||||
| Expression System | HEK293 | ||||
| Theoretical Molecular Weight | 63.9 kDa | ||||
| Apparent Molecular Weight | Due to glycosylation, the protein migrates to 75-85 kDa based on Bis-Tris PAGE result. | ||||
| Formulation | Lyophilized from 0.22μm filtered solution in PBS (pH 7.4). | ||||
| Reconstitution | Centrifuge the tube before opening. Reconstituting to a concentration more than 100 μg/ml is recommended. Dissolve the lyophilized protein in distilled water. | ||||
| Storage & Stability | Upon receiving, the product remains stable for 6 months at -20℃ or below. Upon reconstitution, the product should be stable for 3 months at -80℃. Avoid repeated freeze-thaw cycles. | 
                                                    Immobilized Human CD47, His Tag at 2 μg/ml (100 μl/well) on the plate. Dose response curve for SIRP alpha V2/CD172a hFc Chimera, Human, hFc Tag with the EC50 of 41.9ng/ml determined by ELISA. »
                                                    Immobilized SIRP alpha V2/CD172a hFc Chimera, Human, hFc Tag at 0.5 μg/ml (100 μl/Well) on the plate. Dose response curve for Biotinylated Anti-SIRP alpha Antibody, hFc Tag with the EC50 of 33.9ng/ml determined by ELISA. »
                                                    The purity of SIRP alpha V2/CD172a hFc Chimera, Human is greater than 95% as determined by SEC-HPLC. »
                                                    SIRP alpha V2/CD172a hFc Chimera, Human on Bis-Tris PAGE under reduced condition. The purity is greater than 95%. »
| Target Background | Signal regulatory protein α (SIRPα) is a regulatory membrane glycoprotein from SIRP family expressed mainly by myeloid cells and also by stem cells or neurons.SIRPα acts as inhibitory receptor and interacts with a broadly expressed transmembrane protein CD47 also called the 'don´t eat me' signal.Cancer cells highly expressed CD47 that activate SIRP α and inhibit macrophage-mediated destruction. | 
| Synonyms | CD172a; BIT; MFR; MYD1; MYD-1; P84; PTPNS1; SHPS1; SHPS-1; SIRP alpha; SIRPA; SIRPalpha2 | 
For research use only. Not intended for human or animal clinical trials, therapeutic or diagnostic use.